HEPA
Hepion Pharmaceuticals, Inc. - Common Stock (HEPA)
$06
About Hepion Pharmaceuticals, Inc. - Common Stock (HEPA)
Hepion Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of drug therapy for treatment of chronic liver diseases. It focuses on the development of its product candidate, Rencofilstat, a cyclophilin inhibitor that targets biochemical pathways involved in the progression of liver disease. The company was founded on May 15, 2013 and is headquartered in Morristown, NJ.
Details
Daily high
$0.08
Daily low
$0.06
Price at open
--
52 Week High
$24.50
52 Week Low
$0.03
Market cap
697,200
Dividend yield
0.00%
Volume
3
Avg. volume
25,179
P/E ratio
.00
Hepion Pharmaceuticals, Inc. - Common Stock News
Details
Daily high
$0.08
Daily low
$0.06
Price at open
--
52 Week High
$24.50
52 Week Low
$0.03
Market cap
697,200
Dividend yield
0.00%
Volume
3
Avg. volume
25,179
P/E ratio
.00